focus -WSS

focus

author：focus 2025-08-08 08:10:14 - browse：4611

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft.

The first was her Polish-born maternal grandmother, who began showing symptoms when Schaeffer started college in 1981 and died seven years later. Then came her mother, a onetime Fulbright Scholar and high school language teacher who had been fluent in five languages but lost the ability to speak. She died in 2019. Last year, the disease killed Schaeffer’s mother’s sister, a former lab technician for Johnson & Johnson.

Schaeffer, a 59-year-old costume historian in North Berwick, Maine, has no symptoms of Alzheimer’s. But in 2021 her family history led her to apply to join a clinical trial testing a drug on people at risk for developing them. To participate, volunteers couldn’t have cognitive impairment. But they needed to test positive for a biomarker that put them at higher risk for mental decline ― deposits of a sticky toxic protein in the brain called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Why drug prescriptions should include diagnoses

explore

WSS

With FDA staff opposed to Sarepta therapy, top official intervened

#NeedHerScience: shining a light on gender disparities in medicine

The battle over the Brookhaven Landfill on Long Island

Pumping milk in bathrooms at health conferences is common

Microsoft launches AI tool for clinical documentation through Epic

Donald Trump's relentless attacks on special counsel Jack Smith

Wikipedia

focus

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

A pediatrician calls for Congress to pass the child tax credit deal

Moonlake's readout produced a cash windfall. Risks remain

High breast density mammograms need follow

Anesthesiologist group: stop taking Ozempic before surgery

Prior authorization reform is both possible and imperative

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Colonoscopy at 40? Study finds a possible benefit

State Dept. review finds Biden bears some blame for Afghanistan failures

Flu vaccine reformulation won't be easy, manufacturers warn

hotspot

A pediatrician calls for Congress to pass the child tax credit deal

Flu vaccine reformulation won't be easy, manufacturers warn

What causes osteoarthritis? Researchers study link to brain protein

Dog Aging Project founders on what lies ahead after losing funding

Gene therapy has helped boys walk. Can scientists keep it that way?

Mass General, Mayo Clinic look to monetize custom

explore

explore

explore

focus